BioPharma Pharma Research
Ablaze Pharmaceuticals and Yonghe Pharma Initiate Development and Manufacturing Services Agreement for Targeted Radiopharmaceutical Therapies
"This agreement with Yonghe represents a significant step for Ablaze in our efforts to optimize our preclinical and clinical development program for target...
December 28, 2022 | News
Brii Biosciences Provides Update on Strategic Clinical Development Progress
Initiation of Phase 2 postpartum depression (PPD) study planned for early 2023 to advance potential first-of-its-kind treatment U.S. FDA lifted clinical h...
December 28, 2022 | News
STADA partners with BIAL to bring Ongentys to Parkinson’s patients in Australia
STADA receives from BIAL exclusive rights to market and distribute Ongentys (opicapone) capsules in Australia STADA Specialty Head Bryan Kim: "Ongentys ...
December 19, 2022 | News
Calypso Biotech Announces First Patient with Eosinophilic Esophagitis Dosed in Anti-Interleukin-15 (IL-15) Monoclonal Antibody CALY-002 Phase 1a/b Trial, and Animal Proof of Concept Data in Atopic Dermatitis
Healthy volunteers phase completed showing differentiating target engagement biomarker data and favorable safety data On track for top-line histology da...
December 19, 2022 | News
FDA Approves First Gene Therapy for the Treatment of High-Risk, Non-Muscle-Invasive Bladder Cancer
"This approval provides healthcare professionals with an innovative treatment option for patients with high-risk non-muscle invasive bladder cancer that is...
December 19, 2022 | News
BioVaxys Announces Results from The Ohio State University Pan-Sarbecovirus Animal Study
The Company previously demonstrated that BVX-0320 stimulated a strong antibody and T cell response in a murine model, and believes that administering BVX-1...
December 19, 2022 | News
Eisai and Washington University School of Medicine in St. Louis Enter Into Comprehensive Research Collaboration Agreement Aiming to Create New Therapies for Neurodegenerative Diseases
Washington University is world leading in research on prevention, diagnosis, biomarkers and treatment of neurodegenerative diseases. The two organizations ...
December 15, 2022 | News
Over £175 million for cutting-edge genomics research to help boost diagnosis treatment for patients
£105 million to speed up diagnosis of rare genetic diseases in newborns, potentially resulting in life-saving interventions for thousands of babies...
December 15, 2022 | News
Ascletis Announces Positive Phase I Clinical Results of Oral RdRp Inhibitor ASC10 for COVID-19
Based on Ascletis' Phase I results of ASC10 and molnupiravir's clinical efficacy data in American, Japanese and Chinese patients, 800 mg twice daily of ASC...
December 13, 2022 | News
Fraunhofer IZI Selects Lonza’s MOD A-ES® Solution to Digitalize Manufacturing Operations
The Fraunhofer Institute for Cell Therapy and Immunology (Fraunhofer IZI) has chosen Lonza’s MODA-ES® Manufacturing Execution System (M...
December 06, 2022 | News
Griffith joins $280 million partnership to deliver mRNA vaccine outcomes
The $280 million Translational Science Hub will be established under an agreement between Sanofi, Griffith University, the University of Queensland and the...
December 05, 2022 | News
How Optoacoustic Imaging Plays a Role in Assessing the Success of Breast Cancer Surgery
This first-in-human study was carried out by a team of researchers and clinicians at A*STAR’s Institute of Bioengineering and Bioimaging (IBB)&...
December 05, 2022 | News
Pulmonx Receives Japanese MHLW Approval of Zephyr Endobronchial Valve for the Treatment of Severe COPD/Emphysema
Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, announced today that ...
December 02, 2022 | News
MGI Cements Its Presence and Contribution in Singapore's Genomics Landscape at ESMO Asia Congress 2022
At ESMO, MGI sets to showcase its MGISP-100 Automated Sample Preparation System and DNBSEQ-G99* Genetic Sequencer at Booth C209. Suitable for small and med...
December 02, 2022 | News
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
